 |
Imciromab pentetate |
|---|---|
| Trade Name | Myoscint |
| Orphan Indication | Detecting early necrosis as an indication of rejection of orthotopic cardiac transplants |
| USA Market Approval | USA |
| USA Designation Date | 1989-01-25 00:00:00 |
| Sponsor | Centocor, Inc.;244 Great Valley Parkway;Malvern, Pennsylvania, 19355 |
